<![CDATA[OxOnc Development LP 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=19038>Thu, 14 May 2026 08:58:30 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[OxOnc Announces Agreement With Pfizer to Develop Crizotinib as First-Line and Second-Line Treatment for Patients With ROS1-Positive Non-Small Cell Lung Cancer]]>https://www.newswire.co.kr/newsRead.php?no=678962Mon, 11 Feb 2013 11:58:34 +0900<![CDATA[OxOnc, Pfizer와 ROS1 양성 비소세포폐암 환자를 위한 1차 및 2차 치료용 크리조티닙 개발에 합의]]>https://www.newswire.co.kr/newsRead.php?no=678961Mon, 11 Feb 2013 11:58:08 +0900